A dual-cell therapy cures type 1 diabetes without lifelong drugs

Claim

A dual-cell therapy paired lab-grown beta cells with engineered immune cells to cure type 1 diabetes without lifelong immunosuppression, while the first trial combining fetal surgery with stem cells for spina bifida reversed hindbrain herniation in all six patients.

Reported metric: 6/6 patients

Reporting date: 2026-03-03 (not necessarily the event date)

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

• Welcome to March 3, 2026 (theinnermostloop.substack.com)